-
admin
Posts
KIND Presents Positive Results of AND017 to Treat Anemia Associated with Chronic Kidney Disease in Two Phase II and Two Phase I
Clinical Trials at American Society of Nephrology (ASN) – Kidney Week 2024 SAN FRANCISCO, Oct. 29, 2024 /PRNewswire/ — Kind Pharmaceutical (“Hangzhou Andao Pharmaceutical Ltd....
Covenant House Leads Call to End Youth Homelessness Across the Americas
Covenant House rallies a global community each November to confront the youth homelessness crisis impacting millions. New York City, Oct. 28, 2024 (GLOBE NEWSWIRE) —...
2024 Yellow River Estuary (Dongying) Marathon Kicks Off
DONGYING, China, Oct. 28, 2024 (GLOBE NEWSWIRE) — Run at the Yellow River Estuary and chase dreams in the new era. At 7:30 a.m. on Oct. 20, China...
Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024
Management to host conference call on Thursday, November 7, 2024, at 8:30 am ET FLORHAM PARK, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals,...
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
Expanded collaborations to support rapid testing in advanced animal models in Q4 2024 SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq:...
MBX Biosciences to Participate in Upcoming November Investor Conferences
CARMEL, Ind., Oct. 28, 2024 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
ViaNautis Bio Signs Strategic Collaboration Agreement with Lilly to leverage its polyNaut® platform to develop novel products delivering genetic medicines
ViaNautis Bio Signs Strategic Collaboration Agreement with Lilly to leverage its polyNaut® platform to develop novel products delivering genetic medicines Multi-year collaboration will use ViaNautis’...
Evaxion to announce business update and third quarter 2024 financial results on October 31
COPENHAGEN, Denmark, October 28, 2024 – Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a...
Megatrends in the United States Influencing National Consumer Expenditure
Dublin, Oct. 28, 2024 (GLOBE NEWSWIRE) — The “Megatrends in the US” report has been added to ResearchAndMarkets.com’s offering. This Megatrends report highlights long-term trends...
Ningxia Zhongwei: Electrical Beauty Countryside Abundant Scene
ZHONGWEI, China, Oct. 28, 2024 /PRNewswire/ — “When harvesting corn, we must pay attention to the safety distance between the harvester and the poles and...
